These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 25579386)

  • 21. Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches.
    Olsen JA; Akirav EM
    J Neurosci Res; 2015 May; 93(5):687-96. PubMed ID: 25287108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dale E. McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion.
    Raine CS
    Ann Neurol; 1994; 36 Suppl():S61-72. PubMed ID: 8017891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of maternal separation and antidepressant drug on epigenetic regulation of the brain-derived neurotrophic factor exon I promoter in the adult rat hippocampus.
    Park SW; Seo MK; Lee JG; Hien LT; Kim YH
    Psychiatry Clin Neurosci; 2018 Apr; 72(4):255-265. PubMed ID: 28990703
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis.
    Islam MA; Kundu S; Hassan R
    Curr Gene Ther; 2020; 19(6):376-385. PubMed ID: 32141417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Sclerosis: Basic and Clinical.
    Buzzard K; Chan WH; Kilpatrick T; Murray S
    Adv Neurobiol; 2017; 15():211-252. PubMed ID: 28674983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute treatment with valproic acid and l-thyroxine ameliorates clinical signs of experimental autoimmune encephalomyelitis and prevents brain pathology in DA rats.
    Castelo-Branco G; Stridh P; Guerreiro-Cacais AO; Adzemovic MZ; Falcão AM; Marta M; Berglund R; Gillett A; Hamza KH; Lassmann H; Hermanson O; Jagodic M
    Neurobiol Dis; 2014 Nov; 71():220-33. PubMed ID: 25149263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 18β-glycyrrhetinic acid suppresses experimental autoimmune encephalomyelitis through inhibition of microglia activation and promotion of remyelination.
    Zhou J; Cai W; Jin M; Xu J; Wang Y; Xiao Y; Hao L; Wang B; Zhang Y; Han J; Huang R
    Sci Rep; 2015 Sep; 5():13713. PubMed ID: 26329786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunomodulation neuroprotection and remyelination - the fundamental therapeutic effects of glatiramer acetate: a critical review.
    Aharoni R
    J Autoimmun; 2014 Nov; 54():81-92. PubMed ID: 24934599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opioid growth factor and low-dose naltrexone impair central nervous system infiltration by CD4 + T lymphocytes in established experimental autoimmune encephalomyelitis, a model of multiple sclerosis.
    Hammer LA; Waldner H; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2016 Jan; 241(1):71-8. PubMed ID: 26202376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple epigenetic biomarkers for evaluation of students' academic performance.
    Lee LC; Su MT; Cho YC; Lee-Chen GJ; Yeh TK; Chang CY
    Genes Brain Behav; 2019 Jun; 18(5):e12559. PubMed ID: 30806012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MeCP2 deficiency in the brain decreases BDNF levels by REST/CoREST-mediated repression and increases TRKB production.
    Abuhatzira L; Makedonski K; Kaufman Y; Razin A; Shemer R
    Epigenetics; 2007; 2(4):214-22. PubMed ID: 18075316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis.
    Abdul-Majid KB; Stefferl A; Bourquin C; Lassmann H; Linington C; Olsson T; Kleinau S; Harris RA
    Scand J Immunol; 2002 Jan; 55(1):70-81. PubMed ID: 11841694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-132 Down-regulates Methyl CpG Binding Protein 2 (MeCP2) During Cognitive Dysfunction Following Chronic Cerebral Hypoperfusion.
    Yao ZH; Yao XL; Zhang Y; Zhang SF; Hu J
    Curr Neurovasc Res; 2017; 14(4):385-396. PubMed ID: 29090669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain-Derived Neurotrophic Factor in Central Nervous System Myelination: A New Mechanism to Promote Myelin Plasticity and Repair.
    Fletcher JL; Murray SS; Xiao J
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30572673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic suppression of BDNF via epigenetic mechanism deteriorating learning and memory impairment caused by Mn and Pb co-exposure.
    Wei L; He H; Yang S; Shi Q; Wang X; Huang L; Lu J; Shen Y; Zhi K; Xiang J; Chen C; Mo J; Zheng Z; Zou Y; Yang X; Tang S; Li X; Lu C
    Ecotoxicol Environ Saf; 2024 Jun; 277():116365. PubMed ID: 38657452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.
    Miller RH; Fyffe-Maricich SL
    Dis Model Mech; 2010; 3(9-10):535-9. PubMed ID: 20647413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of MeCP2 in Regulating Synaptic Plasticity in the Context of Stress and Depression.
    Sánchez-Lafuente CL; Kalynchuk LE; Caruncho HJ; Ausió J
    Cells; 2022 Feb; 11(4):. PubMed ID: 35203405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment.
    De Santi L; Polimeni G; Cuzzocrea S; Esposito E; Sessa E; Annunziata P; Bramanti P
    Curr Med Chem; 2011; 18(12):1775-84. PubMed ID: 21466473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.